The presence of estrogen and progesterone receptors in breast cancer cells is a key factor in determining the cancer's characteristics and treatment approach. Cancers that are hormone receptor-positive (ER-positive and/or PR-positive) typically rely on these hormones for growth. As a result, treatments that block the action of these hormones can be effective in slowing or stopping cancer growth.
